Last reviewed · How we verify
JINZHEN Granules for Oral Solution
At a glance
| Generic name | JINZHEN Granules for Oral Solution |
|---|---|
| Sponsor | Lianyungang Kanion Group, Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- JINZHEN for Treatment of Mild to Moderate COVID-19 (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JINZHEN Granules for Oral Solution CI brief — competitive landscape report
- JINZHEN Granules for Oral Solution updates RSS · CI watch RSS
- Lianyungang Kanion Group, Ltd. portfolio CI